Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection

Journal of Infectious Diseases

Volumn 184, Issue 12, 2001, Pages 1508-1517

  Rousseau, M C ^a   Pereira, J S ^b   Prado, J C M ^b   Villa, L L ^b   Rohan, T E ^c   Franco, E L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAZIL; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PERSISTENT VIRUS INFECTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUPERINFECTION; UTERINE CERVICITIS; VACCINATION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; BRAZIL; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 0035892786     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/324579     Document Type: Article

References (26)

1. Human papillamoviruses
2. Prevalence of human papillomavirus in cervical cancer - A worldwide perspective
3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
4. Estimates of the worldwide incidence of 25 major cancers in 1990
5. Human papillomavirus vaccines
6. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine
7. Generation and neutralization of pseudovirions of human papillomavirus type 33
8. In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16
9. In vitro generation and type-specific neutralization or a human papillomavirus type 16 virion pseudotype
10. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition
11. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes
12. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types
13. Concurrent and sequential acquisition of different genital human papillomavirus types
14. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil
15. Genital human papillomavirus infection in female university students as determined by a PCR-based method
16. Persistence of type-specific human papillomavirus infection among cytologically normal women
17. Identification and assessment of known and novel human papillomaviruses by PCR amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms
18. The impact of confounder selection criteria on effect estimation
19. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
20. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia
21. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a case-control study conducted in the United States
22. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women
23. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: Impact of infection with human immunodeficiency virus
24. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
25. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica
26. Natural history of cervicovaginal papillomavirus infection in young women